首页> 外文期刊>PACE: Pacing and clinical electrophysiology >Long-term reproducibility of ventricular tachycardia induction with electrophysiological testing in patients with coronary heart disease and depressed left ventricular ejection fraction.
【24h】

Long-term reproducibility of ventricular tachycardia induction with electrophysiological testing in patients with coronary heart disease and depressed left ventricular ejection fraction.

机译:电生理检查对冠心病和左心室射血分数降低的患者的室性心动过速诱导的长期可重复性。

获取原文
获取原文并翻译 | 示例
           

摘要

The Multicenter Automatic Defibrillator Implantation Trial (MADIT) has recently confirmed the role of programmed ventricular stimulation (PVS) to identify the high risk patients of sudden death after myocardial infarction and to prevent this risk. The purpose of this study was to evaluate the long-term reproducibility of PVS in these patients. Thirty patients with coronary heart disease without spontaneous documented sustained ventricular tachycardia (VT) underwent two programmed stimulations in the absence of antiarrhythmic drug treatment between 2 and 6 years (mean 4 years). No patient had a myocardial infarction or intervening cardiac surgery during this period. The protocol of study was similar using up to three extrastimuli in two sites of the right ventricle, delivered in sinus rhythm and driven rhythm (600 ms, 400 ms, respectively). On the first PVS, 17 patients had inducible sustained VT (group I). Thirteen patients did not have inducible VT (group II). On the second PVS all group I patients but one had inducible VT, but the cycle length was significantly modified in 11. In group II, five patients had inducible VT and in the other patients the PVS remained negative. In conclusion, in patients with coronary heart disease, but without documented VT, the long-term reproducibility of PVS was excellent in those with inducible VT (94%); the patients remain at risk of VT and a prophylactic implantable cardioverter defibrillator could be considered. In patients with initially negative study, reproducibility of PVS was lower (61.5%), probably because of the progressive remodeling after myocardial infarction. Therefore, the occurrence of new symptoms in patients with previously negative study requires a second programmed ventricular stimulation.
机译:最近,多中心自动除颤器植入试验(MADIT)证实了程序性心室刺激(PVS)的作用,可以识别出心肌梗死后猝死的高危患者并预防这种风险。这项研究的目的是评估这些患者中PVS的长期可重复性。在没有抗心律不齐药物治疗的情况下,有30例无自发性持续性冠心病(持续性室速)的患者接受了两次程序性刺激,治疗时间为2年至6年(平均4年)。在此期间,没有患者进行过心肌梗塞或介入性心脏手术。研究方案相似,在右心室的两个部位使用多达三个额外刺激,以窦性心律和驱动性心律(分别为600 ms,400 ms)进行传递。在第一个PVS中,有17例患者发生了诱导性持续VT(第一组)。 13例患者没有诱发性VT(II组)。在第二个PVS上,所有I组患者,但一个患者具有可诱发的VT,但11个周期的周期明显改变。在II组中,五个患者具有可诱发的VT,在其他患者中,PVS保持阴性。总之,在冠心病但无VT记录的患者中,PVS的长期可重复性在可诱发VT的患者中极佳(94%)。患者仍然有室速危险,可以考虑使用预防性植入式心脏复律除颤器。在最初阴性研究的患者中,PVS的重现性较低(61.5%),这可能是由于心肌梗死后进行性重塑。因此,先前阴性研究患者中新症状的发生需要第二次程序性心室刺激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号